Redwood Shores, CA (PRWEB) October 30, 2012
Model N, the leader in Revenue Management solutions, announced today that a leading biopharma manufacturer is deploying Model N Managed Markets ImpACT to improve visibility into performance data and trends across one of its specialty pharma product lines. The company has previously launched Managed Markets ImpACT across one of its other therapeutic lines.
The decision to expand the use of Managed Markets ImpACT came after the company realized that the complexity of sales and market data in its growing specialty product line was limiting its ability to uncover both tactical and strategic performance insights. The company will leverage the application to better serve customers, prioritize account focus, and create a reporting system to answer incremental questions and enable drill downs for Account Managers and Reimbursement Business Managers.
“In this deployment, specialty product Account Managers and Reimbursement Business Managers will be able to gain a more competitive understanding of their performance through a visually rich, turn-key platform that aggregates and connects their third-party and internal data sets in real time,” said Sujay Jadhav, Senior Vice President of Corporate Strategy, Model N. “Our customer has seen tremendous success with Managed Markets ImpACT in its Rx business and we anticipate that this will continue into the specialty product space.”
About Model N Managed Markets ImpACT
Managed Markets ImpACT is a powerful analytics platform that helps Managed Care leaders increase market share with improved account strategies and competitor insights. The Managed Markets ImpACT SaaS platform is a single data source that enables Managed Care leaders to proactively adjust sales strategies in response to competitor formulary changes; align sales, marketing, and finance to meet managed care challenges; and provide Account Managers and sales teams with integrated data and tools to strengthen pull through in the field.
Social Media Links
About Model N
Model N, the leader in Revenue Management solutions, drives improved pricing, margin, and revenue performance through a powerful combination of best practices, highly configurable software applications, comprehensive services, and actionable analytics across the complete functional spectrum of pricing, contracting, rebating, sales, and marketing. Model N leverages its deep industry expertise to support the unique business needs of Life Sciences and High Tech manufacturers across more than 50 countries. Global Customers include: Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell, Hospira, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, STMicroelectronics, and Watson Pharmaceuticals. Whether you are an emerging business or a global leader, Model N results in revenue. http://www.modeln.com
Model N is a trademark of Model N, Inc. All other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.